News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Valera Pharmaceuticals Sets Date For Reporting Third-Quarter 2006 Financials And Milestone Developments
November 1, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CRANBURY, NJ -- (MARKET WIRE) -- November 01, 2006 -- Valera Pharmaceuticals (NASDAQ: VLRX) today said it will report its third-quarter 2006 financial results on Wednesday morning, November 8, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Podcast
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
April 1, 2026
·
1 min read
·
Heather McKenzie
Funding
Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B
April 1, 2026
·
2 min read
·
Tristan Manalac
Company closure
IO Shuts Down Following Regulatory Roadblocks
April 1, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Novo Sheds 400 at Embattled Manufacturing Site
April 1, 2026
·
43 min read
·
BioSpace Editorial Staff
